Should Age Limit the Use of Catheter-Directed Thrombolysis

Abstract

Objective:

To determine whether advanced age should be a contraindication to catheter-directed thrombolysis (CDT) based on hemorrhagic complication rate.

Methods:

A survey was generated via Survey Monkey and sent out to vascular surgeons who were members of the society of vascular surgery (SVS).

Results:

Of the responders, 32.7% state they do not have an age limit for tissue plasminogen activator (TPA) infusion, and the remaining 29.2% of the responders use 80 years of age as their limitation. When asked why place limits on age for TPA infusion, 56.6% stated concern for intracranial hemorrhage. Major complications were access site hemorrhage (58.4%) and intracranial hemorrhage (41.6%). Chi-square analysis did not show age as a limiting factor to thrombolysis. Furthermore, when asked in which age-group complications occurred most commonly, 72.4% were less than 80.

Conclusion:

Among vascular specialist, there seems to be no consensus on age limitations for TPA infusion. Serious complications do not seem to be age related and thus age alone should not be a contraindication for catheter-directed thrombolysis.

Keywords

thrombosis limb ischemia complication hemorrhage

Get full access to this article

View all access options for this article.

References

Neary

Whitman

Foy

Heather

Earnshaw

. Value of POSSUM scoring to assess outcome after intra-arterial thrombolysis for acute limb ischemia. Br J Surg. 2001;88 (10):1344–1345.

Mewissen

Seabrook

Meissner

Cynamon

Labropoulos

Haughton

. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211 (1):39–49.

Blaisdell

Steele

Allen

. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery. 1978;84 (6):822–834.

Jivegard

Holm

Schersten

. The outcome in arterial thrombosis misdiagnosed as arterial embolism. Acta Chir Scand. 1986;152:251–256.

MacDougall

Feliu

Boccuzzi

Lin

. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Phram. 2006 Oct 15;63(20 Suppl 6):S5–15.

Ouriel

Shortell

DeWeese

. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19 (6):1021–1030.

Rafferty

Avellone

Farrell

. A metropolitan experience with infrainguinal revascularization. Operative risk and late results in northeastern Ohio. J Vas Surg. 1987;6 (4):365–371.

Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limb peripheral arterial occlusion—a consensus document. J Vasc Inter Radiol. 2003;14 (9 pt 2):S337–S349.

Earnshaw

Whitman

Foy

. National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg. 2004;39 (5):1018–1025.

10.

Campbell

Rider

BMF

Szymanska

. Current management of acute limb ischemia: results of audit by the Vascular Surgical Society of Great Britain and Ireland. Br J Surg. 1998;85 (11):1498–1503.

11.

Semba

Murphy

Bakal

Calis

Matalon

. Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The advisory panel. J Vasc Interv Radiol. 2000;11 (2 pt 1):149–161.

12.

Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg. 1994;220 (3):251–266.

13.

Ouriel

Veith

Sasahara

. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg. 1996;23 (1):64–73.

14.

Elsharawy

Elzayat

. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24 (3):209